All You Need to Know About VEON (VEON) Rating Upgrade to Strong Buy

VEON Ltd. (VEON) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting a significant improvement in its earnings outlook. This upgrade is primarily driven by a 112% increase in the Zacks Consensus Estimate for the company over the past three months, indicating an enhanced underlying business performance. Such a ranking places VEON in the top 5% of Zacks-covered stocks based on earnings estimate revisions, historically correlating with potential near-term stock price appreciation due to institutional investor activity.

Analysis

VEON Ltd. (VEON) has received a significant ratings upgrade to a Zacks Rank #1 (Strong Buy), placing it in the top 5% of stocks covered by the system. This upgrade is quantitatively driven by a substantial 112% increase in the Zacks Consensus Estimate over the past three months, signaling a powerful positive shift in the company's earnings outlook. The Zacks methodology emphasizes such revisions as a primary catalyst for near-term stock price movements, often influenced by institutional investors adjusting their valuation models and initiating buy-side activity. While the current consensus EPS forecast for the fiscal year ending December 2025 is $10.24, which notably represents no year-over-year change, the dramatic upward revision in this estimate is the key indicator of an improving underlying business trend that is expected to attract investor attention. The historical performance of Zacks Rank #1 stocks, which have generated an average annual return of +25% since 1988, provides a strong statistical context for this bullish signal.

Key Decisions for Investors

• Given the upgrade to a Zacks Rank #1 and the 112% increase in consensus earnings estimates, investors should view VEON as a stock with strong positive near-term momentum.
• It is prudent to investigate the specific drivers behind the significant earnings estimate revision to confirm it reflects sustainable fundamental improvement rather than a one-off adjustment.
• Investors should monitor the trend in analyst consensus estimates closely, as the entire bullish thesis presented is predicated on the continuation of these positive revisions.